http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103463063-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56f3f77865ceaebe064e8d9fb1816c5f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04 |
| filingDate | 2013-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746a5e17338c95b5c937c510da5f80cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53738805ea2de5d0ae448a5d922b326d |
| publicationDate | 2013-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103463063-A |
| titleOfInvention | Application of Lycojaponicumin C in preparation of medicines for treating laryngeal cancer |
| abstract | The invention discloses an application of Lycojaponicumin C in preparation of medicines for treating laryngeal cancer, belonging to the technical field of new applications of medicines. The evaluation on an in vitro MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) anti-tumor activity shows that the Lycojaponicumin C also has an obvious inhibiting effect on the growth of human laryngeal cancer cell lines HEP-2, TU686, M2e and M4e. Therefore, the Lycojaponicumin C can be used for the preparation of the medicines for treating the laryngeal cancer and has good development and application prospects. The application of the Lycojaponicumin C in the preparation of the medicines for treating the laryngeal cancer is disclosed for the first time. As the skeleton type of the Lycojaponicumin C belongs to a brand-new skeleton type, the Lycojaponicumin C has unexpected strong inhibitory activity on laryngeal cancer cells. |
| priorityDate | 2013-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965 |
Total number of triples: 15.